Fast In-House Next-Generation Sequencing in the Diagnosis of Metastatic Non-small Cell Lung Cancer: A Hospital Budget Impact Analysis

Ubong Silas, Maximilian Blüher, Antonia Bosworth Smith, Rhodri Saunders

Keywords: targeted therapy; turnaround time; health economic analysis; hospital costs; genetic testing; return on investment

Journal of Health Economics and Outcomes Research